Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine

Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.

Thomas Kronbach, Daniel Mathys, Makoto Umeno et al. · Molecular Pharmacology · 1989 · 535 citations

Medicine, Pharmacology, Biochemical Pharmacology +15

Identification of a Cannabinoid Analog as a New Type of Designer Drug in a Herbal Product

Nahoko Uchiyama, Ruri Kikura‐Hanajiri, Nobuo Kawahara et al. · Chemical and Pharmaceutical Bulletin · 2009 · 172 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7

Triazolam disposition

F S Eberts, Y Philopoulos, L M Reineke et al. · Clinical Pharmacology & Therapeutics · 1981 · 143 citations

Medicine, Pharmacokinetics, Pharmacology +15

Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in illegal products

Nahoko Uchiyama, Maiko Kawamura, Ruri Kikura‐Hanajiri et al. · Forensic Toxicology · 2012 · 122 citations

Pharmacy, Medicinal Chemistry, Pharmacology +8

<i>In vitro</i>and<i>in vivo</i>glucuronidation of midazolam in humans

Ruth Hyland, Toby Osborne, Anthony G. Payne et al. · British Journal of Clinical Pharmacology · 2009 · 83 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17